Elevations in GDF15 are not limited to these physiological states and in the 20 years since its discovery, increases in the peptide have been reported in a variety of pathological conditions including aging, cardiac failure, chronic kidney disease, mitochondrial disease and malignancy [16, 17]. Here, GDF15 is linked to chronic kidney disease.